-+ 0.00%
-+ 0.00%
-+ 0.00%

SAFI BIOTHERAPEUTICS received a $4.7 million deferred grant from the US Department of Defense Advanced Research Projects Agency to advance the first clinical trial of artificial red blood cells.

Zhitongcaijing·11/03/2026 13:09:27
Listen to the news
SAFI BIOTHERAPEUTICS received a $4.7 million deferred grant from the US Department of Defense Advanced Research Projects Agency to advance the first clinical trial of artificial red blood cells.